These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7577195)

  • 1. Synthesis, analysis and toxicity of three compounds formed during the synthesis of iodixanol.
    Priebe H; Dugstad H; Heglund IF; Sande R; Tønseth CP
    Acta Chem Scand (Cph); 1995 Oct; 49(10):737-43. PubMed ID: 7577195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of iodixanol.
    Priebe H; Dugstad H; Gacek M; Hagen E; Homestad OM; Larsen A; Sjogren CE; Thomassen T
    Acta Radiol Suppl; 1995; 399():21-31. PubMed ID: 8610518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of the X-ray contrast agent iodixanol=3,3',5,5'-tetrakis(2,3-dihydroxypropylcarbamoyl)- 2,2',4,4',6, 6'-hexaiodo-N,N'-(2-hydroxypropane-1,3-diyl)-diacetanili de towards acid, base, oxygen, heat and light.
    Priebe H; Aukrust A; Bjørsvik HR; Tønseth CP; Wiggen UN
    J Clin Pharm Ther; 1999 Jun; 24(3):227-35. PubMed ID: 10438183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium].
    Igarashi M; Nakayama S; Jones E; Shimada H
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():125-31. PubMed ID: 7490784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray contrast agents. I. Synthesis of some derivatives of 5-amino-2,4,6-triiodoisophthalamide.
    Haavaldsen J; Nordal V; Kelly M
    Acta Pharm Suec; 1983; 20(3):219-32. PubMed ID: 6637517
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis, analysis and toxicity of some compounds which may be formed during the synthesis of iopentol.
    Berg A; Fagervoll R; Aulie Michelet A; Dugstad H
    Acta Radiol Suppl; 1987; 370():27-31. PubMed ID: 2980307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding.
    Jacobsen PB; Blindheim L; Skotland T
    Acta Radiol Suppl; 1995; 399():61-6. PubMed ID: 8610531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an HPLC-UV method for iodixanol quantification in human plasma.
    Chitnis SD; Akhlaghi F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):133-7. PubMed ID: 18502708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
    Wang YC; Tang A; Chang D; Zhang SJ; Ju S
    Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats.
    Idée JM; Lancelot E; Berthommier C; Couturier-Goulas V; Vazin V; Corot C
    Fundam Clin Pharmacol; 2000; 14(1):11-8. PubMed ID: 10681069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
    Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature effects on packed-capillary liquid chromatography of the X-ray contrast agent iodixanol.
    Molander P; Theodorsen M; Lundanes E; Soerenssen DM; Greibrokk T
    J Chromatogr Sci; 2000 Apr; 38(4):157-61. PubMed ID: 10766482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural tolerability of iodixanol in mice and dogs after single and repeated intracisternal administration.
    Larsen LE; Heglund IF; Fabian R; Walday P; Blazak WF
    Acta Radiol Suppl; 1995; 399():238-43. PubMed ID: 8610522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple isocratic high-performance liquid chromatographic method for measurement of iodixanol in human plasma.
    Nomura H; Teshima E; Hakusui H
    J Chromatogr; 1991 Dec; 572(1-2):333-8. PubMed ID: 1818070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to rats by repeated intravenous administration for 4 weeks with a 4-week recovery period].
    Ohno H; Crome SJ; Furuhama K; Nomura M; Onodera T
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():67-85. PubMed ID: 7490790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-line dialysis and quantitative high-performance liquid chromatography analysis of iodixanol in human, rat and monkey plasma.
    Jacobsen PB
    J Chromatogr B Biomed Sci Appl; 2000 Nov; 749(1):135-42. PubMed ID: 11129073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodixanol induces apoptotic and antiproliferative effects but no necrotic cell death in renal proximal tubular cells in vitro.
    Heinrich MC; Scheer M; Heckmann M; Kuefner MA; Uder M
    Rofo; 2009 Apr; 181(4):349-54. PubMed ID: 19291604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to cynomolgus monkeys by repeated intravenous administration for 4 weeks with a 4-week recovery period].
    Ohno H; Crome SJ; Genda Y; Furuhama K; Nomura M; Onodera T
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():87-105. PubMed ID: 7490791
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.